Global OTC Analgesics: A Nicholas Hall report on OTC pain relief markets around the world
Discover all there is to know about the Global OTC Analgesics market with this report, which contains multi-country coverage and detailed reporting of individual categories and brands. Incorporating mid-2015 OTC sales from Nicholas Hall’s DB6 Global OTC Database, the report features the latest trends & developments, in-depth brand case studies, and vital insight into factors affecting individual markets.Country chapters drill down to the details, including brand sales and growth, the legal status of ingredients, A+P campaigns, and category sales split by ingredient.
Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Poland, Russia, UK, USA
Key questions addressed:
Global Analgesics Overview
- Which markets are enjoying the most dynamism?
- Can brands in mature markets continue to grow when faced with increasing saturation and generic competition?
- Do any untapped opportunities remain?
- How is marketing changing to reflect consumer needs?
- Are new product development and format innovation helping to bolster growth?
Including consumer trends, a region by region breakdown and topline category trendsLeading Analgesics Markets
14 countries profiled, featuring key trends, individual category analysis, regulatory developments, success factors behind leading segments and brands, and forecasts for the future
Brand Case Studies
Looking at some of the biggest and fastest-growing Analgesics brands, such as Dorflex, Loxonin, Tylenol and Voltaren, and the factors behind their successGlobal Analgesics Outlook
Predicting future prospects for the global Analgesics industry and opportunities & threats in individual markets, including sales forecasts to 2019 and 2024